全球非激素避孕產品市場（2023-2030）：按性別（男/女）、產品類型（避孕套/子宮托）和分銷渠道（零售藥房/醫院）劃分的規模、份額、增長分析和預測

全球非激素避孕產品市場規模預計將從 2021 年的 271 億美元增長到 2022 年的 288.6 億美元，複合年增長率為 6.5%，預計到 2030 年將達到 477.7 億美元。至1000萬美元。

由於人們對非激素避孕產品的認識和採用不斷提高，非激素避孕產品的全球市場正在經歷顯著增長。 非激素避孕方法，例如避孕套、宮內節育器 (IUD)、隔膜以及基於生育意識的方法，提供了副作用較少的替代避孕方法。 人們對激素避孕風險的日益關注、自然避孕方法的趨勢以及可用性和負擔能力的提高等因素都有助於市場的擴張。 此外，非激素避孕技術的進步和產品開發的創新正在推動市場進一步增長。

全球非激素避孕行業對天然和有機避孕產品的需求正在激增。 消費者意識的提高是由於對激素避孕相關潛在副作用的擔憂，導致消費者尋求不含合成激素和化學物質的更安全的替代品。 天然和有機非激素避孕藥具，例如避孕套和自然計劃生育，由於其安全性和環境友好性而越來越受歡迎。 此外，人們對可持續發展和環境意識的不斷增強也推動了向自然避孕的轉變。

在本報告中，我們研究了全球非激素避孕產品市場，提供了市場概況，分析了市場上的各種影響因素、技術和創新趨勢、市場規模的轉變和預測，總結了細分，競爭格局、主要公司概況等

內容

執行摘要

調查方法

母公司市場分析

• 市場概況
• 市場規模
• 市場動態
  • 驅動程序
  • 機會
  • 制約因素
  • 任務

主要市場洞察

• 技術分析
• 價格分析
• 供應鏈分析
• 價值鏈分析
• 市場生態系統
• 知識產權分析
• 貿易分析
• 啟動分析
• 原材料分析
• 創新矩陣
• 管道產品分析
• 宏觀經濟指標
• 主要投資分析
• 關鍵成功因素
• 爭用程度

市場動態與展望

• 市場動態
  • 驅動程序
  • 機會
  • 制約因素
  • 任務
• 監管狀況
• 波特的分析
• Skyquest 對未來顛覆的特殊洞察

全球非激素避孕產品市場：按性別

• 市場概況
• 男性
• 女性

全球非激素避孕產品市場：按產品類型

• 市場概況
• 安全套
• 子宮托
• 宮頸帽
• 殺精劑
• 避孕海綿

全球非激素避孕產品市場：按分銷渠道劃分

• 市場概況
• 零售藥店
• 醫院藥房
• 網上藥店
• 其他

全球非激素避孕產品市場：按地區

• 市場概況
• 北美
• 歐洲
• 亞太地區
• 拉丁美洲
• 中東和非洲

競爭格局

• 排名前 5 名的公司比較
• 主要公司的市場定位
• 各大公司的招聘策略
• 關鍵成功策略
• 近期市場活動
• 主要公司的市場份額

主要公司簡介

• Bayer AG
• Merck &Co., Inc.
• Allergan
• Cooper Surgical Inc.
• Mayer Laboratories, Inc.
• The Female Health Company
• Agile Therapeutics
• Afaxys, Inc.
• Pfizer Inc.
• Teva Pharmaceutical Industries Ltd.
• Church &Dwight Co., Inc.
• The Population Council, Inc.
• Ansell Ltd.
• Medicines360
• Mylan NV
• Okamoto Industries Inc.
• Reckitt Benckiser Group plc
• V-Care Pharma Pvt. Ltd.
• Fuji Latex Co., Ltd.
• Veru Inc.

Market Insights

Global Non-Hormonal Contraception Market size was valued at USD 27.1 billion in 2021 and is poised to grow from USD 28.86 billion in 2022 to USD 47.77 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

The Global Non-Hormonal Contraception Market is experiencing significant growth due to increasing awareness and adoption of non-hormonal contraceptive methods. Non-hormonal contraceptives, such as condoms, intrauterine devices (IUDs), diaphragms, and fertility awareness-based methods, offer alternatives to hormonal birth control with fewer side effects. Factors such as rising concerns over hormonal contraception risks, preference for natural birth control options, and improved accessibility and affordability contribute to the market expansion. Additionally, advancements in non-hormonal contraceptive technologies and innovations in product development further drive market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of non-hormonal contraception market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Non-Hormonal Contraception Market Segmental Analysis

Global Non-Hormonal Contraception market is segmented by gender, product type, and distribution Channel. Based on gender, the Non-Hormonal Contraception Market can be segmented into male, and female. Based on product type, the Non-Hormonal Contraception Market can be segmented into condoms, diaphragms, cervical caps, spermicides, and contraceptive sponges. Based on distribution channel, the Non-Hormonal Contraception Market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, and others. Based on region, the Non-Hormonal Contraception Market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Driver

The Non-Hormonal Contraception Market is being driven by the growing awareness about contraception. As more individuals become educated about the various contraceptive options available, there is an increased interest in non-hormonal methods. These alternatives, such as condoms, IUDs, diaphragms, and fertility awareness-based methods, are gaining popularity due to their lower risk of hormonal side effects. Additionally, the preference for natural birth control options and the improvement in accessibility and affordability of non-hormonal contraceptives are contributing to the market's growth. Ongoing advancements and innovations in non-hormonal contraceptive technologies further fuel this positive trend.

Restraints

Constraints in the Non-Hormonal Contraception Market include limited availability and awareness, particularly in developing countries. Access to non-hormonal contraceptive options is often restricted in these regions, leading to a lack of awareness and understanding of the benefits they offer. The focus on traditional contraceptive methods and the limited availability of modern non-hormonal options hinders the widespread adoption of these alternatives. Overcoming these challenges requires targeted efforts to increase availability, education, and awareness about non-hormonal contraceptive methods in developing countries to empower individuals with more choices for family planning.

Market Trends

The global non-hormonal contraception industry is the surging demand for natural and organic contraceptive products. This rising consumer awareness is driven by concerns over potential side effects linked to hormonal contraception, prompting individuals to seek safer alternatives free from synthetic hormones and chemicals. Natural and organic non-hormonal contraceptives, like condoms and natural family planning methods, are gaining popularity due to their perceived safety and eco-friendliness. Furthermore, the increasing emphasis on sustainability and environmental consciousness is fueling the shift towards these nature-based contraceptive options.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Non-Hormonal Contraception Market by Gender

• Market Overview
• Male and Female

Global Non-Hormonal Contraception Market by Product type

• Market Overview
• Condoms
• Diaphragms
• Cervical Caps
• Spermicides
• and Contraceptive Sponges

Global Non-Hormonal Contraception Market by Distribution channel

• Market Overview
• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies
• and Others

Global Non-Hormonal Contraception Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2021
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2021

Key Company Profiles

• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allergan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cooper Surgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mayer Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Female Health Company
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agile Therapeutics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Afaxys, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Church & Dwight Co., Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• The Population Council, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ansell Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medicines360
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Okamoto Industries Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reckitt Benckiser Group plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• V-Care Pharma Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fuji Latex Co., Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Veru Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments